海森药业
(001367)
| 流通市值：6.58亿 | | | 总市值：25.33亿 |
| 流通股本：1767.21万 | | | 总股本：6800.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 951,780,526.11 | 943,753,478.62 | 926,648,132.36 | 908,359,821.62 |
| 应收票据及应收账款 | 59,050,949.66 | 54,315,161.63 | 43,558,257.01 | 59,365,398.5 |
| 其中：应收票据 | 6,277,771.29 | 2,583,679.83 | - | - |
| 应收账款 | 52,773,178.37 | 51,731,481.8 | 43,558,257.01 | 59,365,398.5 |
| 应收款项融资 | 30,475,027.89 | 3,412,853.5 | 12,187,665.16 | 23,143,159.99 |
| 预付款项 | 2,419,587.08 | 2,251,647.46 | 4,448,702.74 | 2,639,786.3 |
| 其他应收款合计 | 119,163.08 | 72,373.05 | 152,892.84 | 76,810.82 |
| 存货 | 130,308,371.03 | 159,308,105.77 | 158,104,654.48 | 139,935,714.61 |
| 其他流动资产 | 11,006,384.06 | 14,865,038.2 | 15,605,138.26 | 10,125,566.18 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,185,160,008.91 | 1,177,978,658.23 | 1,160,705,442.85 | 1,143,646,258.02 |
| 非流动资产: | | | | |
| 投资性房地产 | 4,081,920.13 | 4,157,676.85 | 4,233,433.57 | 4,309,190.29 |
| 固定资产 | 92,413,181.52 | 86,340,287.08 | 85,134,549.6 | 81,523,228.14 |
| 在建工程 | 41,980,275.8 | 48,052,260.88 | 23,726,191.86 | 18,506,097.31 |
| 使用权资产 | 8,768,539.79 | 503,495.42 | 511,023.35 | 548,321.93 |
| 无形资产 | 19,777,185.02 | 19,778,228.44 | 19,518,146.45 | 19,658,271.8 |
| 长期待摊费用 | 197,958.82 | 257,544.55 | 781,903.59 | 1,117,754.82 |
| 递延所得税资产 | - | - | 1,515,352.5 | 1,613,311.91 |
| 其他非流动资产 | 3,430,088.16 | 3,882,638.37 | 5,135,965.01 | 5,713,501.59 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 170,649,149.24 | 162,972,131.59 | 140,556,565.93 | 132,989,677.79 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,355,809,158.15 | 1,340,950,789.82 | 1,301,262,008.78 | 1,276,635,935.81 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 25,792,204.26 | 46,554,235.59 | 37,304,923.18 | 43,979,727.74 |
| 其中：应付票据 | 5,770,000 | 13,930,000 | 14,070,000 | 19,237,500 |
| 应付账款 | 20,022,204.26 | 32,624,235.59 | 23,234,923.18 | 24,742,227.74 |
| 合同负债 | 5,293,261.29 | 4,159,355.53 | 6,208,328.4 | 5,661,352.7 |
| 应付职工薪酬 | 6,744,335.3 | 13,192,509.31 | 9,599,701.04 | 8,354,292.44 |
| 应交税费 | 6,093,653.53 | 7,500,377.84 | 8,032,802.33 | 6,214,133.06 |
| 其他应付款合计 | 4,845,195.72 | 4,760,698.25 | 5,298,340.45 | 4,154,525.62 |
| 一年内到期的非流动负债 | 953,956.74 | 67,011.38 | 807,547.98 | 814,350.54 |
| 其他流动负债 | 2,311,420.6 | 2,539,927.36 | 4,145,305.65 | 3,884,673.59 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 52,034,027.44 | 78,774,115.26 | 71,396,949.03 | 73,063,055.69 |
| 非流动负债: | | | | |
| 租赁负债 | 7,926,867.53 | 99,891.75 | - | - |
| 递延收益 | 5,853,176.13 | 5,853,176.13 | 5,865,458.75 | 5,765,458.75 |
| 递延所得税负债 | 6,904,877.54 | 6,888,951.83 | 7,727,657.21 | 7,414,381.96 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 20,684,921.2 | 12,842,019.71 | 13,593,115.96 | 13,179,840.71 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 72,718,948.64 | 91,616,134.97 | 84,990,064.99 | 86,242,896.4 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 68,000,000 | 68,000,000 | 68,000,000 | 68,000,000 |
| 资本公积 | 763,020,230.3 | 763,020,230.3 | 763,020,230.3 | 763,020,230.3 |
| 专项储备 | 1,617,343.88 | 1,246,559.35 | 919,970.46 | 1,159,989.28 |
| 盈余公积 | 41,682,014.06 | 41,682,014.06 | 41,682,014.06 | 41,682,014.06 |
| 未分配利润 | 408,770,621.27 | 375,385,851.14 | 342,649,728.97 | 316,530,805.77 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,283,090,209.51 | 1,249,334,654.85 | 1,216,271,943.79 | 1,190,393,039.41 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,283,090,209.51 | 1,249,334,654.85 | 1,216,271,943.79 | 1,190,393,039.41 |
| 负债和股东权益合计 | 1,355,809,158.15 | 1,340,950,789.82 | 1,301,262,008.78 | 1,276,635,935.81 |
| 公告日期 | 2024-04-25 | 2024-04-23 | 2023-10-30 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |